Midazolam Nasal Spray (USL261) Phase 3 Trial Meets Primary Efficacy Endpoint In Patients With Seizure Clusters

Posted on:

CAMBRIDGE, England, April 26, 2017 /PRNewswire/ — Proximagen Limited (Proximagen) today announced that its pivotal Phase 3 trial of intranasal midazolam (USL261) for the rescue treatment of seizure clusters, met its primary efficacy endpoint in a top-level analysis of the data. Based on these findings, Proximagen will approach the U.S. Food…  Read More

Exciting advancement for adolescents living with migraines!

Posted on:

FDA Approves Expanded Indication for Qudexy® XR (topiramate) Extended-Release Capsules to Include Prophylaxis of Migraine Headache in Adults and Adolescents Molecule Most Prescribed by Neurologists for Migraine Prophylaxis Now Available in a Unique 24-hour Formulation MAPLE GROVE, Minn., March 30, 2017 /PRNewswire/ — Upsher-Smith Laboratories, Inc. (Upsher-Smith) today announced that…  Read More

Rare Neurological Disease Special Report

Posted on:

Neurology Reviews presents its third annual Rare Neurological Disease Special Report, a compendium of articles and information covering a wide range of rare neurologic diseases. CNF is committed to the awareness and education of these rare conditions as evidenced by its newly-convened RARE Child Neurology Workgroup – a collaborative workgroup with…  Read More

Novartis drug Votubia® receives EU approval to treat refractory partial-onset seizures in patients with TSC

Posted on:

MEDIA RELEASE • COMMUNIQUE AUX MEDIAS Novartis International AG Novartis Global Communications CH-4002 Basel Switzerland http://www.novartis.com • MEDIENMITTEILUNG Novartis drug Votubia® receives EU approval to treat refractory partial-onset seizures in patients with TSC   Votubia is the first adjunctive treatment approved in the EU specifically for partial- onset seizures in…  Read More

Posted on:

Creatine helps supply energy to all cells in the body. It helps increase adenosine triphosphate (ATP). Creatine is produced in the liver, which makes it out of three amino acids: arginine, glycine and methionine. Most of our body’s creatine (approximately 95%) is stored in the muscles that support the skeleton….  Read More

Novartis drug Votubia® receives EU approval to treat refractory partial-onset seizures in patients with TSC

Posted on:

Basel, January 31, 2017 – Novartis today announced that the European Commission has approved Votubia® (everolimus) dispersible tablets* as an adjunctive treatment for patients aged two years and older whose refractory partial-onset seizures, with or without secondary generalization, are associated with tuberous sclerosis complex (TSC). Votubia is now the first…  Read More

Special Needs Horseback Competition Provides Fun For Participants

Posted on:

The 121st Fort Worth Stock Show offers fun and entertainment for lots of fans. However for more than 200 horseback riders with special needs the real fun happened before the show officially began. These young riders are competing in the Chisholm Challenge. For participants the Chavez family, day to day life…  Read More

Carrie Fisher’s Last Advice, “As Your Bipolar Sister”

Posted on:

Star Wars fans around the world were saddened to hear about the passing of Carrie Fisher. Along with being a great actress, she was also a championed awareness for those dealing with depression, bipolar disorder, and other brain disorders. In an advice column published on Nov. 30. Fisher was asked, “Have…  Read More

Special Needs Ice Competition

Posted on:

Outside of Chicago a group of special needs athletes were participating in the 2017 Champions Special Needs Skating Competition. For the participants, it’s not just about the competition. It’s about sharing their love for skating with others. The Competition took place on Jan 7 at the Franklin Park Ice Arena. Over 100 athletes from…  Read More